Article

Formoterol dry-powder inhaler for the treatment of asthma and chronic obstructive pulmonary disease.

Division of Immunology and Allergy, UCSD College of Medicine Allergy Associates Medical Group, Inc., 6386 Alvarado Court Suite 210, San Diego, California 92120, USA.
Expert Opinion on Pharmacotherapy (impact factor: 3.2). 01/2008; 8(17):3069-84. DOI:10.1517/14656566.8.17.3069 pp.3069-84
Source: PubMed

ABSTRACT Formoterol, a long-acting beta2-adrenergic agonist, is used as an inhaled bronchodilator therapy for patients with asthma or for the prevention of exercise-induced bronchospasm in children and in chronic obstructive pulmonary disease. Formoterol has unique characteristics of rapid onset and sustained duration of action compared with other bronchodilators. In addition to its effectiveness as regular maintenance therapy in asthma and chronic obstructive pulmonary disease, formoterol is also reported to be effective as an as-needed reliever therapy in patients with asthma. Formoterol is available in several different types of dry-powder inhalers and pressurized metered-dose inhalers.

0 0
 · 
0 Bookmarks
 · 
38 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

as-needed reliever therapy
 
bronchodilators
 
chronic obstructive pulmonary disease
 
different types
 
dry-powder inhalers
 
exercise-induced bronchospasm
 
inhaled bronchodilator therapy
 
long-acting beta2-adrenergic agonist
 
pressurized metered-dose inhalers
 
regular maintenance therapy